Enochian Biosciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Enochian Biosciences is scheduled to report earnings on May 15, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	$ 53.31K	$ 53.31K	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 53.31K	$ 53.31K	-	-	-
EBIT	$ -4.06M	$ -4.37M	$ -7.60M	$ -90.14M	$ -6.11M
EBITDA	$ -4.04M	$ -4.34M	$ -7.58M	$ -90.11M	$ -6.07M
Net Income Common Stockholders	$ -4.33M	$ -4.46M	$ -7.70M	$ -90.24M	$ -6.20M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 2.95M	-	$ 7.97M	$ 9.17M	$ 11.15M
Total Assets	$ 78.20M	-	$ 83.07M	$ 84.63M	$ 180.10M
Total Debt	$ 7.04M	$ 0.00	$ 6.99M	$ 7.02M	$ 7.32M
Net Debt	$ 4.09M	$ 0.00	$ -986.73K	$ -2.16M	$ -3.83M
Total Liabilities	$ 12.60M	-	$ 12.75M	$ 12.01M	$ 18.86M
Stockholders Equity	$ 66.13M	-	$ 70.32M	$ 72.62M	$ 161.24M
Cash Flow	-
Free Cash Flow	$ -3.31M	$ -3.41M	$ -2.82M	$ -3.05M	$ -2.78M
Operating Cash Flow	$ -3.31M	$ -3.38M	$ -2.82M	$ -3.05M	$ -2.78M
Investing Cash Flow	-	$ -23.63K	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 2.11M	$ -466.63K	$ 1.63M	$ 1.07M	$ 229.53K

Currency in USD

Enochian Biosciences Earnings and Revenue History

Income Statement >

Enochian Biosciences Debt to Assets

Balance Sheet >

Enochian Biosciences Cash Flow

Cash Flow >

Enochian Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing